Skip to content
← Full study record

NCT00334282 · BASELINE

Baseline characteristics

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma · Source last updated 2016-02-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      290
    2. group Id
      BG001
      value
      145
    3. group Id
      BG002
      value
      435
    units
    Participants
groups
  1. description
    Pazopanib 800 mg (tablets) administered orally once a day
    id
    BG000
    title
    Pazopanib 800 mg
  2. description
    Matching Placebo administered once a day
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.06
          value
          59.1
        2. group Id
          BG001
          spread
          11.04
          value
          59.6
        3. group Id
          BG002
          spread
          10.38
          value
          59.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          92
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          128
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          307
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          252
        2. group Id
          BG001
          value
          122
        3. group Id
          BG002
          value
          374
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          36
        2. group Id
          BG001
          value
          23
        3. group Id
          BG002
          value
          59
      title
      Asian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      African American/African Heritage
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      Native Hawaiian or other Pacific Islander
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      290
    2. group Id
      BG001
      value
      145
    3. group Id
      BG002
      value
      435
    units
    Participants
groups
  1. description
    Pazopanib 800 mg (tablets) administered orally once a day
    id
    BG000
    title
    Pazopanib 800 mg
  2. description
    Matching Placebo administered once a day
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.06
          value
          59.1
        2. group Id
          BG001
          spread
          11.04
          value
          59.6
        3. group Id
          BG002
          spread
          10.38
          value
          59.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          92
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          128
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          307
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          252
        2. group Id
          BG001
          value
          122
        3. group Id
          BG002
          value
          374
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          36
        2. group Id
          BG001
          value
          23
        3. group Id
          BG002
          value
          59
      title
      Asian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      African American/African Heritage
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      Native Hawaiian or other Pacific Islander
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice